20%+ revenue growth in FY27
Management expects to maintain 20%+ revenue growth driven by capacity ramp-up, product portfolio expansion, and market penetration.
INNOVACAPTAB / guidance tracker
Keep management guidance in view.
Innova Captab · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
EBITDA growth to outpace revenue growth in FY27
With improving scale and operating leverage, EBITDA growth is expected to exceed revenue growth, aided by Jammu facility ramp-up.
PAT growth to outpace EBITDA growth as Jammu scales
As depreciation and interest costs are largely fixed, incremental revenue from Jammu will drive PAT growth faster than EBITDA.
Capex of INR 150-170 cr for new Baddi facility over FY27-28
A new general oral block at Baddi is planned with capex spread over two years, expected to generate INR 450-500 cr revenue at optimum level.